1 Market Overview of Wilson's Disease Drugs 1.1 Wilson's Disease Drugs Market Overview 1.1.1 Wilson's Disease Drugs Product Scope 1.1.2 Wilson's Disease Drugs Market Status and Outlook 1.2 Global Wilson's Disease Drugs Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Wilson's Disease Drugs Market Size by Region (2016-2027) 1.4 Global Wilson's Disease Drugs Historic Market Size by Region (2016-2021) 1.5 Global Wilson's Disease Drugs Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Wilson's Disease Drugs Market Size (2016-2027) 1.6.1 North America Wilson's Disease Drugs Market Size (2016-2027) 1.6.2 Europe Wilson's Disease Drugs Market Size (2016-2027) 1.6.3 Asia-Pacific Wilson's Disease Drugs Market Size (2016-2027) 1.6.4 Latin America Wilson's Disease Drugs Market Size (2016-2027) 1.6.5 Middle East & Africa Wilson's Disease Drugs Market Size (2016-2027) 2 Wilson's Disease Drugs Market Overview by Type 2.1 Global Wilson's Disease Drugs Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Wilson's Disease Drugs Historic Market Size by Type (2016-2021) 2.3 Global Wilson's Disease Drugs Forecasted Market Size by Type (2022-2027) 2.4 Hepatic 2.5 Neuropsychiatric 2.6 Ophthalmic 2.7 Others 3 Wilson's Disease Drugs Market Overview by Application 3.1 Global Wilson's Disease Drugs Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Wilson's Disease Drugs Historic Market Size by Application (2016-2021) 3.3 Global Wilson's Disease Drugs Forecasted Market Size by Application (2022-2027) 3.4 Hospitals 3.5 Clinic 3.6 Others 4 Wilson's Disease Drugs Competition Analysis by Players 4.1 Global Wilson's Disease Drugs Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Wilson's Disease Drugs as of 2020) 4.3 Date of Key Players Enter into Wilson's Disease Drugs Market 4.4 Global Top Players Wilson's Disease Drugs Headquarters and Area Served 4.5 Key Players Wilson's Disease Drugs Product Solution and Service 4.6 Competitive Status 4.6.1 Wilson's Disease Drugs Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Kadmon Holdings, Inc. 5.1.1 Kadmon Holdings, Inc. Profile 5.1.2 Kadmon Holdings, Inc. Main Business 5.1.3 Kadmon Holdings, Inc. Wilson's Disease Drugs Products, Services and Solutions 5.1.4 Kadmon Holdings, Inc. Wilson's Disease Drugs Revenue (US$ Million) & (2016-2021) 5.1.5 Kadmon Holdings, Inc. Recent Developments 5.2 Merck & Co. 5.2.1 Merck & Co. Profile 5.2.2 Merck & Co. Main Business 5.2.3 Merck & Co. Wilson's Disease Drugs Products, Services and Solutions 5.2.4 Merck & Co. Wilson's Disease Drugs Revenue (US$ Million) & (2016-2021) 5.2.5 Merck & Co. Recent Developments 5.3 Teva Pharmaceutical Industries Limited 5.5.1 Teva Pharmaceutical Industries Limited Profile 5.3.2 Teva Pharmaceutical Industries Limited Main Business 5.3.3 Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Products, Services and Solutions 5.3.4 Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Revenue (US$ Million) & (2016-2021) 5.3.5 Tsumura & Co. Recent Developments 5.4 Tsumura & Co. 5.4.1 Tsumura & Co. Profile 5.4.2 Tsumura & Co. Main Business 5.4.3 Tsumura & Co. Wilson's Disease Drugs Products, Services and Solutions 5.4.4 Tsumura & Co. Wilson's Disease Drugs Revenue (US$ Million) & (2016-2021) 5.4.5 Tsumura & Co. Recent Developments 5.5 Valeant Pharmaceuticals International, Inc. 5.5.1 Valeant Pharmaceuticals International, Inc. Profile 5.5.2 Valeant Pharmaceuticals International, Inc. Main Business 5.5.3 Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Products, Services and Solutions 5.5.4 Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Revenue (US$ Million) & (2016-2021) 5.5.5 Valeant Pharmaceuticals International, Inc. Recent Developments 5.6 VHB Life Sciences, Inc. 5.6.1 VHB Life Sciences, Inc. Profile 5.6.2 VHB Life Sciences, Inc. Main Business 5.6.3 VHB Life Sciences, Inc. Wilson's Disease Drugs Products, Services and Solutions 5.6.4 VHB Life Sciences, Inc. Wilson's Disease Drugs Revenue (US$ Million) & (2016-2021) 5.6.5 VHB Life Sciences, Inc. Recent Developments 5.7 Wilson Therapeutics AB (Alexion) 5.7.1 Wilson Therapeutics AB (Alexion) Profile 5.7.2 Wilson Therapeutics AB (Alexion) Main Business 5.7.3 Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Products, Services and Solutions 5.7.4 Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Revenue (US$ Million) & (2016-2021) 5.7.5 Wilson Therapeutics AB (Alexion) Recent Developments ... 6 North America 6.1 North America Wilson's Disease Drugs Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Wilson's Disease Drugs Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Wilson's Disease Drugs Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Wilson's Disease Drugs Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Wilson's Disease Drugs Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Wilson's Disease Drugs Market Dynamics 11.1 Wilson's Disease Drugs Industry Trends 11.2 Wilson's Disease Drugs Market Drivers 11.3 Wilson's Disease Drugs Market Challenges 11.4 Wilson's Disease Drugs Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Wilson's Disease Drugs Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Wilson's Disease Drugs Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Wilson's Disease Drugs Market Size Share by Region (2016-2021) Table 4. Global Wilson's Disease Drugs Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Wilson's Disease Drugs Forecasted Market Size Share by Region (2022-2027) Table 6. Global Wilson's Disease Drugs Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Wilson's Disease Drugs Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Wilson's Disease Drugs Revenue Market Share by Type (2016-2021) Table 9. Global Wilson's Disease Drugs Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Wilson's Disease Drugs Revenue Market Share by Type (2022-2027) Table 11. Global Wilson's Disease Drugs Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Wilson's Disease Drugs Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Wilson's Disease Drugs Revenue Market Share by Application (2016-2021) Table 14. Global Wilson's Disease Drugs Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Wilson's Disease Drugs Revenue Market Share by Application (2022-2027) Table 16. Global Wilson's Disease Drugs Revenue (US$ Million) by Players (2016-2021) Table 17. Global Wilson's Disease Drugs Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Wilson's Disease Drugs as of 2020) Table 19. Date of Key Manufacturers Enter into Wilson's Disease Drugs Market Table 20. Global Wilson's Disease Drugs Top Players Headquarters and Area Served Table 21. Wilson's Disease Drugs Product Solution and Service Table 22. Global Wilson's Disease Drugs Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Kadmon Holdings, Inc. Basic Information List Table 25. Kadmon Holdings, Inc. Description and Business Overview Table 26. Kadmon Holdings, Inc. Wilson's Disease Drugs Products, Services and Solutions Table 27. Revenue (US$ Million) in Wilson's Disease Drugs Business of Kadmon Holdings, Inc. (2016-2021) Table 28. Kadmon Holdings, Inc. Recent Developments Table 29. Merck & Co. Basic Information List Table 30. Merck & Co. Description and Business Overview Table 31. Merck & Co. Wilson's Disease Drugs Products, Services and Solutions Table 32. Revenue (US$ Million) in Wilson's Disease Drugs Business of Merck & Co. (2016-2021) Table 33. Merck & Co. Recent Developments Table 34. Teva Pharmaceutical Industries Limited Basic Information List Table 35. Teva Pharmaceutical Industries Limited Description and Business Overview Table 36. Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Products, Services and Solutions Table 37. Revenue (US$ Million) in Wilson's Disease Drugs Business of Teva Pharmaceutical Industries Limited (2016-2021) Table 38. Teva Pharmaceutical Industries Limited Recent Developments Table 39. Tsumura & Co. Basic Information List Table 40. Tsumura & Co. Description and Business Overview Table 41. Tsumura & Co. Wilson's Disease Drugs Products, Services and Solutions Table 42. Revenue (US$ Million) in Wilson's Disease Drugs Business of Tsumura & Co. (2016-2021) Table 43. Tsumura & Co. Recent Developments Table 44. Valeant Pharmaceuticals International, Inc. Basic Information List Table 45. Valeant Pharmaceuticals International, Inc. Description and Business Overview Table 46. Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Products, Services and Solutions Table 47. Revenue (US$ Million) in Wilson's Disease Drugs Business of Valeant Pharmaceuticals International, Inc. (2016-2021) Table 48. Valeant Pharmaceuticals International, Inc. Recent Developments Table 49. VHB Life Sciences, Inc. Basic Information List Table 50. VHB Life Sciences, Inc. Description and Business Overview Table 51. VHB Life Sciences, Inc. Wilson's Disease Drugs Products, Services and Solutions Table 52. Revenue (US$ Million) in Wilson's Disease Drugs Business of VHB Life Sciences, Inc. (2016-2021) Table 53. VHB Life Sciences, Inc. Recent Developments Table 54. Wilson Therapeutics AB (Alexion) Basic Information List Table 55. Wilson Therapeutics AB (Alexion) Description and Business Overview Table 56. Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Products, Services and Solutions Table 57. Revenue (US$ Million) in Wilson's Disease Drugs Business of Wilson Therapeutics AB (Alexion) (2016-2021) Table 58. Wilson Therapeutics AB (Alexion) Recent Developments Table 59. North America Wilson's Disease Drugs Market Size by Country (2016-2021) & (US$ Million) Table 60. North America Wilson's Disease Drugs Market Size by Country (2022-2027) & (US$ Million) Table 61. Europe Wilson's Disease Drugs Market Size by Country (2016-2021) & (US$ Million) Table 62. Europe Wilson's Disease Drugs Market Size by Country (2022-2027) & (US$ Million) Table 63. Asia-Pacific Wilson's Disease Drugs Market Size by Region (2016-2021) & (US$ Million) Table 64. Asia-Pacific Wilson's Disease Drugs Market Size by Region (2022-2027) & (US$ Million) Table 65. Asia-Pacific Wilson's Disease Drugs Market Share by Region (2016-2021) Table 66. Asia-Pacific Wilson's Disease Drugs Market Share by Region (2022-2027) Table 67. Latin America Wilson's Disease Drugs Market Size by Country (2016-2021) & (US$ Million) Table 68. Latin America Wilson's Disease Drugs Market Size by Country (2022-2027) & (US$ Million) Table 69. Middle East & Africa Wilson's Disease Drugs Market Size by Players (2016-2021) & (US$ Million) Table 70. Middle East & Africa Wilson's Disease Drugs Market Size by Country (2022-2027) & (US$ Million) Table 71. Wilson's Disease Drugs Market Trends Table 72. Wilson's Disease Drugs Market Drivers Table 73. Wilson's Disease Drugs Market Challenges Table 74. Wilson's Disease Drugs Market Restraints Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Global Wilson's Disease Drugs Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Wilson's Disease Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Wilson's Disease Drugs Market Share by Regions: 2021 VS 2027 Figure 4. Global Wilson's Disease Drugs Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Wilson's Disease Drugs Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Wilson's Disease Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Wilson's Disease Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Wilson's Disease Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Wilson's Disease Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Wilson's Disease Drugs Market Size Share by Type in 2021 & 2027 Figure 11. Hepatic Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Neuropsychiatric Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Ophthalmic Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Global Wilson's Disease Drugs Market Size Share by Application in 2021 & 2027 Figure 16. Hospitals Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Clinic Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Wilson's Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Top 5 and Top 10 Players Wilson's Disease Drugs Market Share in 2020 Figure 21. North America Wilson's Disease Drugs Market Share by Country (2016-2027) Figure 22. United States Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 23. Canada Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 24. Germany Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 25. France Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 26. U.K. Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 27. Italy Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 28. Russia Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 29. Nordic Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 30. Rest of Europe Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 31. Asia-Pacific Wilson's Disease Drugs Market Share by Region (2016-2027) Figure 32. China Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 33. Japan Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 34. South Korea Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 35. Southeast Asia Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 36. India Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 37. Australia Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 38. Rest of Asia-Pacific Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 39. Latin America Wilson's Disease Drugs Market Share by Country (2016-2027) Figure 40. Mexico Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 41. Brazil Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 42. Rest of Latin America Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 43. Middle East & Africa Wilson's Disease Drugs Market Share by Country (2016-2027) Figure 44. Turkey Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 45. Saudi Arabia Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 46. UAE Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 47. Rest of Middle East & Africa Wilson's Disease Drugs Market Size (2016-2027) & (US$ Million) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation

Kadmon Holdings, Inc. Merck & Co. Teva Pharmaceutical Industries Limited Tsumura & Co. Valeant Pharmaceuticals International, Inc. VHB Life Sciences, Inc. Wilson Therapeutics AB (Alexion)